IL-6 can influence the autoimmune response in seropositive RA by promoting Th17/Treg imbalance and can synergize with IL-21 to mediate antibody production, further exacerbating autoantibody production in seropositive RA (71, 72). Here, IL21 is linked to rheumatoid arthritis.